Metalloprotease-disintegrin ADAM8: Expression analysis and targeted deletion in mice

Developmental Dynamics

Volumn 232, Issue 1, 2005, Pages 221-231

  Kelly, Kristine ^a,b   Hutchinson, Gillian ^c   Nebenius Oosthuizen, Daniela ^d   Smith, Andrew J H ^d   Bartsch, Jörg W ^e   Horiuchi, Keisuke ^a   Rittger, Andrea ^e   Manova, Katia ^a   Docherty, Andy J P ^c   Blobel, Carl P ^a,f  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c UCB PHARMA   (Belgium)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e BIELEFELD UNIVERSITY   (Germany)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ADAM; CD156a; Lymphatic development; Metalloprotease disintegrin; MS2

Indexed keywords

DISINTEGRIN; MEMBRANE ENZYME; METALLOPROTEINASE; PROTEIN ADAM8; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BRAIN DEVELOPMENT; CARTILAGE; CONTROLLED STUDY; DECIDUA; DEGENERATIVE DISEASE; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; GENE DELETION; GENE EXPRESSION; GONAD; INNER CELL MASS; JUGULAR VEIN; MACROPHAGE; MESENCHYME; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPINAL CORD; THYMUS; TROPHOBLAST;

ADAM PROTEINS; ALLELES; ANIMALS; ANTIGENS, CD; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BONE AND BONES; BONE DEVELOPMENT; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LAC OPERON; MACROPHAGES; MALE; MEMBRANE PROTEINS; MESODERM; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; MUTATION; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 19944428083     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.20221     Document Type: Article

References (53)

1. Amour A, Knight C, English W, Webster A, Slocombe P, Knauper V, Docherty A, Becherer J, Blobel C, Murphy G. 2002. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett 524:154-158.
2. Black RA, White JM. 1998. ADAMs: focus on the protease domain. Curr Opin Cell Biol 10:654-659.
3. Black R, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. 1997. A metalloprotease disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729-733.
4. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA. 1998. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273:27765-27767.
5. Choi SJ, Han JH, Roodman GD. 2001. ADAM8: a novel osteoclast stimulating factor. J Bone Miner Res 16:814-822.
6. Clarke HR, Wolfson MF, Rauch CT, Castner BJ, Huang CP, Gerhart MJ, Johnson RS, Cerretti DP, Paxton RJ, Price VL, Black RA. 1998. Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae. Protein Expr Purif 13:104-110.
7. Fambrough D, Pan D, Rubin GM, Goodman CS. 1996. The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila. Proc Natl Acad Sci. USA 93:13233-13238.
8. Fourie AM, Coles F, Moreno V, Karlsson L. 2003. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem 278:30469-30477.
9. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. 2001. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276:37993-38001.
10. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena Illert A, von Figura K, Saftig P. 2002. The disintegrin/metalloprotease ADAM 10 is essential for Notch signaling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11:2615-2624.
11. Higuchi Y, Yasui A, Matsuura K, Yamamoto S. 2002. CD156 transgenic mice. Different responses between inflammatory types. Pathobiology 70:47-54.
12. Hodgkinson CP, Ye S. 2003. Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages. Biochem Biophys Res Commun 308:505-510.
13. Hooper NM, Turner AJ. 2000. Protein processing mechanisms: from angiotensin-converting enzyme to Alzheimer's disease. Biochem Soc Trans 28:441-446.
14. Hooper NM, Karran EH, Turner AJ. 1997. Membrane protein secretases. Biochem J 321:265-279.
15. Horiuchi K, Weskamp G, Lum L, Hammes HP, Cai H, Brodie TA, Ludwig T, Chiusaroli R, Baron R, Preissner KT, Manova K, Blobel CP. 2003. Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol 23:5614-5624.
16. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, Lee DC. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22:2704-2716.
17. Kataoka M, Yoshiyama K, Matsuura K, Hijiya N, Higuchi Y, Yamamoto S. 1997. Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location. J Biol Chem 272:18209-18215.
18. Kurohara K, Komatsu K, Kurisaki T, Masuda A, Irie N, Asano M, Sudo K, Nabeshima Y, Iwakura Y, Sehara-Fujisawa A. 2004. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol 267:14-28.
19. Lieber T, Kidd S, Young MW. 2002. Kuzbanian-mediated cleavage of Drosophila Notch. Genes Dev 16:209-221.
20. Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM. 1998. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem 273:16993-16997.
21. Lum L, Reid MS, Blobel CP. 1998. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem 273:26236-26247.
22. Mandelin J, Li TF, Hukkanen MV, Liljestrom M, Chen ZK, Santavirta S, Kitti U, Konttinen YT. 2003. Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J Rheumatol 30:2033-2038.
23. Manova K, Nocka K, Besmer P, Bachvarova RF. 1990. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057-1069.
24. Mansour SL, Thomas KR, Capecchi MR. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived cells: a general strategy for targeting mutations to nonselectable genes. Nature 336:348-352.
25. Merlos-Suarez A, Ruiz-Paz S, Baselga J, Arribas J. 2001. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem 276:48510-48517.
26. Moss ML, Jin S-LC, Milla ME, Burkhart W, Cartner HL, Chen W-J, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Lessnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su J-L, Warner J, Willard D, Becherer JD. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733-736.
27. Mountford P, Zevnik B, Duwel A, Nichols J, Li M, Dani C, Robertson M, Chambers I, Smith A. 1994. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A 91:4303-4307.
28. Nehls M, Kyewski B, Messerle M, Waldschutz R, Schuddekopf K, Smith AJ, Boehm T. 1996. Two genetically separable steps in the differentiation of thymic epithelium. Science 272:886-889.
29. Oliver G. 2004. Lymphatic vasculature development. Nat Rev Immunol 4:35-45.
30. Pan D, Rubin J. 1997. KUZBANIAN controls proteolytic processing of NOTCH and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90:271-280.
31. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russel WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA. 1998. An essential role for ectodomain shedding in mammalian development. Science 282:1281-1284.
32. Primakoff P, Myles DG. 2000. The ADAM gene family: surface proteins with an adhesion and protease activity packed into a single molecule. Trends Genet 16:83-87.
33. Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. 1999. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem 274:3531-3540.
34. Rooke J, Pan D, Xu T, Rubin GM. 1996. KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273:1227-1230.
35. Sahin U, Weskamp G, Zhou HM, Higashiyama S, Peschon JJ, Hartmann D, Saftig P, Blobel CP. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR-ligands. J Cell Biol 164:769-779.
36. Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW. 2000. Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J Neurosci 20:7964-7971.
37. Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJ, Lambert M, Skelton L, Jockusch H, Bartsch JW. 2002. The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J Biol Chem 277:48210-48219.
38. Schlöndorff J, Becherer JD, Blobel CP. 2000. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 347(Pt 1):131-138.
39. Schlöndorff J, Blobel CP. 1999. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein ectodomain shedding. J Cell Sci 112:3603-3617.
40. Schluesener HJ. 1998. The disintegrin domain of ADAM 8 enhances protection against rat experimental autoimmune encephalomyelitis, neuritis and uveitis by a polyvalent autoantigen vaccine. J Neuroimmunol 87:197-202.
41. Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7-30.
42. Sotillos S, Roch F, Campuzano S. 1997. The metalloprotease-disintegrin Kuzbanian participates in Notch activation during growth and patterning of Drosophila imaginal discs. Development 124:4769-4779.
43. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W. 1995. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 4:823-840.
44. Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC. 2002. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277:12838-12845.
45. Thathiah A, Blobel CP, Carson DD. 2003. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem 278:3386-3394.
46. Thomas KR, Folger KR, Capecchi MR. 1986. High frequency targeting of genes to specific sites in the mammalian genome. Cell 44:419-428.
47. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, Umland SP, Egan RW, Cuss FM, Rorke S, Clough JB, Holloway JW, Holgate ST, Keith TP. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418:426-430.
48. Weskamp G, Cai H, Brodie TA, Higashyama S, Manova K, Ludwig T, Blobel CP. 2002. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol 22:1537-1544.
49. Weskamp G, Schlöndorff J, Lum L, Saftig P, Hartmann D, Becherer D, Murphy G, Blobel CP. 2004. Evidence for a critical role of the TNFa convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 279:4241-4249.
50. White JM. 2003. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15:598-606.
51. Yoshida S, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. 1990. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int Immunol 2:586-591.
52. Yoshiyama K, Higuchi Y, Kataoka M, Matsuura K, Yamamoto S. 1997. CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics 41:56-62.
53. Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, Chiusaroli R, Hahn R, Wilkes D, Fisher P, Baron R, Manova K, Basson CT, Hempstead BL, Blobel CP. 2004. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 24:96-104.